Stephanie Patterson, MD, FACR, FSBI, Clinical Professor, Radiology, Division of Breast Imaging, University of Michigan, Michigan Medicine speaks about Tomosynthesis Mammographic Imaging Screening Trial (TMIST).
This is an ongoing study.
Link to Study:
www.cancer.gov/tmist
TMIST is a randomized breast screening experiment that will aid researchers in determining the best methods for detecting breast cancer in women with no symptoms. It compares two types of digital mammography approved by the Food and Drug Administration (FDA): regular digital mammography (2-D) and tomosynthesis mammography, a newer technology (3-D). To obtain a flat image, 2-D mammography captures photos from two sides of the breast. 3-D mammography images are obtained from various angles around the breast and then stitched together to create a three-dimensional image.
Breast cancer screening aims to detect the disease early on, when it may be easier to treat. The purpose of this study is to see if 3-D mammography is superior to 2-D mammography for breast cancer screening.
The trial also includes the creation of a tissue bank for future research. All women who sign up for the study will be asked to provide tissue samples such as blood and swabs of cells from their mouths. Researchers believe that the data from these tissue samples can one day assist tailor breast cancer screening by taking into account a person’s genetics and other particular risk factors.